Cardiovascular Health
Lexeo LX2006 Gene Therapy Trial Targets Cardiac Endpoint in Friedreich Ataxia
The open-label study design and 6-month topline readout signal an accelerated path toward regulatory submission for the…
Cardiovascular Health 5 stories
Cardiovascular Health
Lorundrostat Linked to Heart Failure Biomarker Reductions in Proteomic Analysis
Late-breaking findings presented at the Endocrine Society Annual Meeting add cardiovascular biomarker evidence to the a…
Cardiovascular Health
Teverelix® Phase 2b Filing Targets High-CV-Risk Prostate Cancer Niche
The underserved patient segment represents an estimated $4 billion annual market opportunity, according to the company.
Cardiovascular Health
Oliv18 Olive Polyphenol Supplement Targets Cardio, Antioxidant Markets
Olive polyphenols are gaining formulation traction as dual-certification positioning signals cleaner-label credibility …
Cardiovascular Health
Lomitapide EU Approval Expands to Pediatric Rare Lipid Disorder
The EC label expansion targets an ultra-rare genetic LDL disorder — a reminder of how orphan-drug pipelines intersect w…